Literature DB >> 31205251

Effect of High-Intensity Exercise on Multiple Sclerosis Function and Phosphorous Magnetic Resonance Spectroscopy Outcomes.

Anna Orban1, Bharti Garg2, Manoj K Sammi3, Dennis N Bourdette1, William D Rooney3, Kerry Kuehl2, Rebecca I Spain1,4.   

Abstract

PURPOSE: We determined if a high-intensity aerobic exercise program would be safe, improve expected fitness and clinical outcomes, and alter exploratory phosphorous magnetic resonance spectroscopy (P MRS) outcomes in persons with multiple sclerosis (PwMS).
METHODS: This open-label prospective pilot study compared two cohorts of ambulatory PwMS matched for age, sex and V˙O2max. Cohorts underwent 8 wk of high-intensity aerobic exercise (MS-Ex, n = 10) or guided stretching (MS-Ctr, n = 7). Aerobic exercise consisted of four 30-min sessions per week while maintaining ≥70% maximal HR. Changes in cardiorespiratory fitness, clinical outcomes, and P MRS of tibialis anterior (TA) muscle and brain were compared. Cross-sectional P MRS comparisons were made between all MS participants and a separate matched healthy control population.
RESULTS: The MS-Ex cohort achieved target increases in V˙O2max (mean, +12.7%; P = <0.001, between-group improvement, P = 0.03). One participant was withdrawn for exercise-induced syncope. The MS-Ex cohort had within-group improvements in fat mass (-5.8%; P = 0.04), lean muscle mass (+2.6%; P = 0.02), Symbol Digit Modalities Test (+15.1%; P = 0.04), and cognitive subscore of the Modified Fatigue Impact Scale (-26%; P = 0.03), whereas only the physical subscore of the Modified Fatigue Impact Scale improved in MS-Ctr (-16.1%; P = 0.007). P MRS revealed significant within-group increases in MS-Ex participants in TA rate constant of phosphocreatine (PCr) recovery (+31.5%; P = 0.03) and adenosine triphosphate/PCr (+3.2%; P = 0.01), and near significant between-group increases in TA PCr recovery rate constant (P = 0.05) but no significant changes in brain P MRS after exercise. Cross-sectional differences existed between MS and healthy control brain PCr/inorganic phosphate (4.61 ± 0.44, 3.93 ± 0.19; P = 0.0019).
CONCLUSIONS: High-intensity aerobic exercise in PwMS improved expected cardiorespiratory and clinical outcomes but provoked one serious adverse event. The P MRS may serve to explore underlying mechanisms by which aerobic exercise exerts cerebral benefits.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31205251      PMCID: PMC6594188          DOI: 10.1249/MSS.0000000000001914

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  37 in total

Review 1.  Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions.

Authors:  Hans Lassmann; Jack van Horssen
Journal:  Biochim Biophys Acta       Date:  2015-10-08

2.  Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis.

Authors:  Ruchika Shaurya Prakash; Erin M Snook; Robert W Motl; Arthur F Kramer
Journal:  Brain Res       Date:  2009-06-25       Impact factor: 3.252

3.  Fitness and its association with fatigue in persons with multiple sclerosis.

Authors:  E Sebastião; E A Hubbard; R E Klaren; L A Pilutti; R W Motl
Journal:  Scand J Med Sci Sports       Date:  2016-10-17       Impact factor: 4.221

4.  Endurance training is feasible in severely disabled patients with progressive multiple sclerosis.

Authors:  A G Skjerbæk; M Næsby; K Lützen; A B Møller; E Jensen; I Lamers; E Stenager; U Dalgas
Journal:  Mult Scler       Date:  2013-09-20       Impact factor: 6.312

5.  Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial.

Authors:  Giancarlo Coghe; Federica Corona; Elisabetta Marongiu; Giuseppe Fenu; Jessica Frau; Lorena Lorefice; Antonio Crisafulli; Manuela Galli; Alberto Concu; Maria Giovanna Marrosu; Massimiliano Pau; Eleonora Cocco
Journal:  J Neurol       Date:  2018-03-24       Impact factor: 4.849

6.  Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

Authors:  B A Parmenter; B Weinstock-Guttman; N Garg; F Munschauer; R H B Benedict
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

7.  A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.

Authors:  Y C Learmonth; R Marshall-McKenna; L Paul; P Mattison; L Miller
Journal:  Disabil Rehabil       Date:  2012-06-02       Impact factor: 3.033

Review 8.  Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Mark R Scudder; John DeLuca
Journal:  Neuropsychol Rev       Date:  2016-07-22       Impact factor: 7.444

9.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

Review 10.  Physical activity and cognitive function in individuals over 60 years of age: a systematic review.

Authors:  Ashley Carvalho; Irene Maeve Rea; Tanyalak Parimon; Barry J Cusack
Journal:  Clin Interv Aging       Date:  2014-04-12       Impact factor: 4.458

View more
  3 in total

Review 1.  Effects of Different Exercise Therapies on Balance Function and Functional Walking Ability in Multiple Sclerosis Disease Patients-A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Zikang Hao; Xiaodan Zhang; Ping Chen
Journal:  Int J Environ Res Public Health       Date:  2022-06-11       Impact factor: 4.614

2.  HIGH-VOLUME AND HIGH-INTENSITY FUNCTIONAL TRAINING IN PATIENTS WITH MULTIPLE SCLEROSIS: A PILOT STUDY ON FEASIBILITY AND FUNCTIONAL CAPACITY.

Authors:  Tom C A Derikx; Ingrid M H Brands; Arne T Goedhart; Wouter H Hoens; Majanka H Heijenbrok-Kal; Rita H J G VAN DEN Berg-Emons
Journal:  J Rehabil Med Clin Commun       Date:  2022-04-07

Review 3.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.